JP2005536525A5 - - Google Patents

Download PDF

Info

Publication number
JP2005536525A5
JP2005536525A5 JP2004526104A JP2004526104A JP2005536525A5 JP 2005536525 A5 JP2005536525 A5 JP 2005536525A5 JP 2004526104 A JP2004526104 A JP 2004526104A JP 2004526104 A JP2004526104 A JP 2004526104A JP 2005536525 A5 JP2005536525 A5 JP 2005536525A5
Authority
JP
Japan
Prior art keywords
particle
particles
particles according
drug
crystalline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004526104A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005536525A (ja
Filing date
Publication date
Priority claimed from US10/213,907 external-priority patent/US20040028746A1/en
Application filed filed Critical
Publication of JP2005536525A publication Critical patent/JP2005536525A/ja
Publication of JP2005536525A5 publication Critical patent/JP2005536525A5/ja
Pending legal-status Critical Current

Links

JP2004526104A 2002-08-06 2003-07-14 制御された沈澱（再結晶化）法を用いて、製造された結晶質薬物粒子 Pending JP2005536525A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/213,907 US20040028746A1 (en) 2002-08-06 2002-08-06 Crystalline drug particles prepared using a controlled precipitation (recrystallization) process
PCT/US2003/021882 WO2004012710A1 (en) 2002-08-06 2003-07-14 Crystalline drug particles prepared using a controlled precipitation (recrystallization) process

Publications (2)

Publication Number Publication Date
JP2005536525A JP2005536525A (ja) 2005-12-02
JP2005536525A5 true JP2005536525A5 (enExample) 2006-08-31

Family

ID=31494557

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004526104A Pending JP2005536525A (ja) 2002-08-06 2003-07-14 制御された沈澱（再結晶化）法を用いて、製造された結晶質薬物粒子

Country Status (8)

Country Link
US (1) US20040028746A1 (enExample)
EP (1) EP1545463B1 (enExample)
JP (1) JP2005536525A (enExample)
CN (1) CN100356905C (enExample)
AT (1) ATE537815T1 (enExample)
AU (1) AU2003249195A1 (enExample)
CA (1) CA2494277A1 (enExample)
WO (1) WO2004012710A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0327723D0 (en) 2003-09-15 2003-12-31 Vectura Ltd Pharmaceutical compositions
CN114394909B (zh) * 2021-12-31 2024-06-07 大连新阳光材料科技有限公司 对氨基苯甲酸微粉的制备方法
PT4489884T (pt) 2023-01-18 2025-10-15 Nanoform Finland Oyj Um método para cristalização de ingredientes farmacêuticos ativos

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4826689A (en) * 1984-05-21 1989-05-02 University Of Rochester Method for making uniformly sized particles from water-insoluble organic compounds
US5145684A (en) * 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
SE9101090D0 (sv) * 1991-04-11 1991-04-11 Astra Ab Process for conditioning of water-soluble substances
US5716642A (en) * 1995-01-10 1998-02-10 Nano Systems L.L.C. Microprecipitation of nanoparticulate pharmaceutical agents using surface active material derived from similar pharmaceutical agents
SE9501384D0 (sv) * 1995-04-13 1995-04-13 Astra Ab Process for the preparation of respirable particles
US5715642A (en) * 1995-08-16 1998-02-10 Steel Framing Supply Steel-frame system and member
US6287693B1 (en) * 1998-02-25 2001-09-11 John Claude Savoir Stable shaped particles of crystalline organic compounds
US6869617B2 (en) * 2000-12-22 2005-03-22 Baxter International Inc. Microprecipitation method for preparing submicron suspensions
EP1436057B1 (en) * 2001-10-17 2006-04-19 E.I. du Pont de Nemours and Company Rotor-stator apparatus and process for the formation of particles

Similar Documents

Publication Publication Date Title
US20230126007A1 (en) Nanoparticles encapsulating soluble biologics, therapeutics, and imaging agents
Yu et al. Sustained release of antineoplastic drugs from chitosan-reinforced alginate microparticle drug delivery systems
ES2224002T3 (es) Formulaciones farmaceuticas que contienen darifenacina.
KR101378645B1 (ko) 신규한 나노입자
US9820939B2 (en) Antiviral compositions
HUP0002524A2 (hu) Fekélyellenes hatóanyagot tartalmazó orális gyógyászati készítmények és eljárás azok előállítására
ITMI20002456A1 (it) Microsfere di enzimi pancreatici con elevata stabilita' e relativo metodo di preparazione
Hussein‐Al‐Ali et al. Preparation of chitosan nanoparticles as a drug delivery system for perindopril erbumine
RU2010138925A (ru) Микрочастица и ее фармацевтическая композиция
DE69900544D1 (de) Pharmazeutische zusammensetzungen in form von polymeren mikropartikeln erhalten durch extrusion und bildung von kügelchen
JP2024539137A (ja) 上皮組織の慢性炎症性傷害、化生、異形成、および癌を処置するための方法および組成物
US20130344116A1 (en) Oral particle consisting of an amorphous structure and a submicron domain
JP2005536525A5 (enExample)
Chen et al. Oral Delivery of Transformable Bilirubin Self‐Assembled System for Targeted Therapy of Colitis
CN1541091A (zh) 包含酸不稳定活性成分的混悬液形式的药物制剂
CN1878539A (zh) 含苦味药物和pH敏感性聚合物的掩味的药物组合物
US20050269722A1 (en) Process for the preparation of pharmaceutical microcapsules with enhanced taste-masking and high dissolution rate
CN101080217B (zh) 含有用防粘剂微粉化的肠溶聚合物的肠溶型包衣组合物
TWI612978B (zh) 口溶膜
JP2010200853A (ja) コーティング粒子の製造方法
CN104923133A (zh) 尺寸形状独立可控的聚电解质微胶囊的制备方法
El-Feky et al. Preparation, in vitro and in vivo evaluation of oral indomethacin-HP-Β-cyclodextrin loaded chitosan nanoparticles
Anal et al. Biopolymeric micro-and nanoparticles: Preparation, characterization and industrial applications
KR102259005B1 (ko) 담체 구조, 약물 담체, 그 제조 방법 및 그 용도
CN106999442A (zh) 用于制备药物‑聚合物组合物的方法